{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:06:40Z","timestamp":1782922000845,"version":"3.54.5"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Purine-rich element-binding protein A (PUR\u03b1) regulates multiple cellular processes. Rare <jats:italic>de novo<\/jats:italic> mutations can lead to PURA syndrome, which manifests as a range of multisystem disturbances, including hypotonia, global developmental delay, swallowing disorders, apnea, seizures, visual impairments, and congenital heart defects. We report the case of a Colombian girl with no relevant medical history who was diagnosed with PURA syndrome at the age of 7, due to a heterozygous mutation located at 5q31.2, specifically the variant c.697_699del (p.Phe233del), in exon 1 of the PURA gene. This represents the first documented case of PURA syndrome in South America and the first association of the syndrome with vitiligo, thereby expanding the known phenotypic spectrum. In addition to enriching the literature concerning the phenotypic diversity of PURA syndrome, this report highlights, for the first time, the diagnostic challenges faced by developing countries like Colombia in diagnosing high-burden rare diseases such as PURA syndrome.<\/jats:p>","DOI":"10.3389\/fped.2024.1323014","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:55:45Z","timestamp":1711601745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: Expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo"],"prefix":"10.3389","volume":"12","author":[{"given":"S.","family":"Mora-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Casta\u00f1o-Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto Alejandro","family":"Nati-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barahona Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mora Arbel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gordillo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Izquierdo-Condoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/hmg\/ddr476","article-title":"Lack of pur-alpha alters postnatal brain development and causes megalencephaly","volume":"21","author":"Hokkanen","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/jmedgenet-2014-102798","article-title":"Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability","volume":"51","author":"Hunt","year":"2014","journal-title":"J Med Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1212\/NXG.0000000000000613","article-title":"PURA-related developmental and epileptic encephalopathy","volume":"7","author":"Johannesen","year":"2021","journal-title":"Neurol Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/jmedgenet-2017-104946","article-title":"PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature","volume":"55","author":"Reijnders","year":"2018","journal-title":"J Med Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"638217","DOI":"10.3389\/fgene.2021.638217","article-title":"The molecular function of PURA and its implications in neurological diseases","volume":"12","author":"Molitor","year":"2021","journal-title":"Front Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","article-title":"Vitiligo: pathogenesis, clinical variants and treatment approaches","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo pathogenesis and emerging treatments","volume":"35","author":"Rashighi","year":"2017","journal-title":"Dermatol Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The genetic basis of vitiligo","volume":"141","author":"Spritz","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1562","DOI":"10.1002\/mgg3.1562","article-title":"Expanding the PURA syndrome phenotype: a child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa","volume":"9","author":"Cinquina","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41439-022-00189-7","article-title":"Expanding the PURA syndrome phenotype with manifestations in a Japanese female patient","volume":"9","author":"Fukuda","year":"2022","journal-title":"Hum Genome Var"},{"key":"B12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.21037\/tp-20-248","article-title":"Neonatal PURA syndrome: a case report and literature review","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Pediatr"},{"key":"B13","article-title":"Global patient registry\u2014PURA syndrome foundation","year":"2022"},{"key":"B14","doi-asserted-by":"publisher","first-page":"a000356","DOI":"10.1101\/mcs.a000356","article-title":"De novo mutations in PURA are associated with hypotonia and developmental delay","volume":"1","author":"Tanaka","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gene.2017.12.004","article-title":"PURA, the gene encoding pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions","volume":"643","author":"Daniel","year":"2018","journal-title":"Gene"},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ajmg.a.38521","article-title":"Expanding the neurodevelopmental phenotype of PURA syndrome","volume":"176","author":"Lee","year":"2018","journal-title":"Am J Med Genet A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13039-015-0193-9","article-title":"Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA","volume":"8","author":"Bonaglia","year":"2015","journal-title":"Mol Cytogenet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1200\/EDBK_249695","article-title":"HPV vaccination in Latin America: global challenges and feasible solutions","volume":"39","author":"Nogueira-Rodrigues","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12041-019-1165-3","article-title":"A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem","volume":"99","author":"Rodr\u00edguez-Garc\u00eda","year":"2020","journal-title":"J Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajhg.2014.09.014","article-title":"Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome","volume":"95","author":"Lalani","year":"2014","journal-title":"Am J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mdc3.13272","article-title":"Complex movement disorders in a boy with PURA syndrome","volume":"8","author":"Lin","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/ajmg.a.36108","article-title":"5q31.3 microdeletion syndrome: clinical and molecular characterization of two further cases","author":"Brown","year":"2013","journal-title":"Am J Med Genet A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/ajmg.a.35439","article-title":"Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome","author":"Hosoki","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/ajmg.a.33891","article-title":"A new microdeletion syndrome of 5q31.3 characterized by severe developmental delays, distinctive facial features, and delayed myelination","author":"Shimojima","year":"2011","journal-title":"Am J Med Genet A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1122009","DOI":"10.3389\/fpubh.2023.1122009","article-title":"Global prevalence of developmental disabilities in children and adolescents: a systematic umbrella review","volume":"11","author":"Olusanya","year":"2023","journal-title":"Front Public Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1323014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:55:49Z","timestamp":1711601749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1323014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":25,"alternative-id":["10.3389\/fped.2024.1323014"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1323014","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"article-number":"1323014"}}